Pediatric Cancer Research Foundation 2024: Translational Research Grants
No Applicants // Limit: 1 // Tickets Available: 1
These grants fund new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with high- risk cancers. This Grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy. Applicants must be a PhD and/or MD.
Grant Criteria and Eligibility:
- The probability of an advance in prevention, diagnosis or treatment for the near-term
- The novelty of the concept and strategy
- The clarity of presentation
- The overall plan for bringing the research findings to clinical application
- Experience, background, and qualifications of the investigators
- Adequacy of resources and environment (facilities, patients, etc.)
- PCRF only funds non-profit institutions and they must be located in the US.
- PCRF does not have citizenship requirements for our investigators. However, the Principal Investigator needs to be employed by a non-profit U.S. institution that has an affiliation with a hospital.
- Basic Science Research and Translational Grants require the applicant to be a PhD and/or MD.
- Emerging Investigator applicants must have completed two years of their fellowship, or not more than two years as a junior faculty instructor or assistant professor at the start of the award period.